Clinical Trial Update: Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease

View source ↗

Summary

This clinical trial update reports results from a completed study evaluating the combination of rotigotine (Neupro) and L-dopa in patients with Parkinson's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• L-Dopa (Levodopa)
• Neupro (rotigotine)

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Idiopathic Parkinson's Disease | Status: COMPLETED